Acrivastine
Back to searchMolecule Structure
Scientific Name
Acrivastine
Description of the Drug
Acrivastine is an antihistamine agent used for the symptomatic relief of seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09488
http://www.drugbank.ca/drugs/DB09488
Brand Name(s)
Benadryl allgy relief plus decongest, Semprex
Company Owner(s)
Auxilium Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4702 | |
| Human Metabolome Database | HMDB0240231 | |
| DrugBank | DB09488 | |
| PubChem: Thomson Pharma | 14827611 | |
| PubChem | 5284514 | 40466858 |
| LINCS | LSM-45461 | |
| Nikkaji | J22.097C | |
| BindingDB | 50487466 | |
| EPA CompTox Dashboard | DTXSID6022555 | |
| DrugCentral | 82 | |
| ChemicalBook | CB7494671 | |
| rxnorm | ACRIVASTINE | |
| PubChem: Drugs of the Future | 12012900 | |
| ChEBI | 83168 | |
| ZINC | ZINC000003776633 |
